SPC
MYGN icon

Sigma Planning Corp’s Myriad Genetics MYGN Stock Holding History

Sigma Planning Corp’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,415
Closed -$227K – 748
2015
Q1 		$227K Buy
6,415
+450
+8% +$16.1K 0.03% 631
2014
Q4 		$203K Buy
+5,965
New +$212K 0.03% 629

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sigma Planning Corp's MYGN Position: Q2 2015 in Review

Sigma Planning Corp sold out of Myriad Genetics (MYGN) in Q2 2015, closing a stake of 6,415 shares — an estimated $227K sold.

Sigma Planning Corp first reported a position in MYGN in Q4 2014 and held it in 2 quarters. The position peaked at $227K in Q1 2015. 234 funds tracked by Wall St. Rank hold MYGN as of Q2 2015.

  • Sigma Planning Corp reported no remaining Myriad Genetics position as of Q2 2015 after selling out during the quarter.
  • Sigma Planning Corp sold 6,415 Myriad Genetics shares in Q2 2015, an estimated $227K.
  • Sigma Planning Corp first reported a position in Myriad Genetics in Q4 2014 and held it in 2 quarters.
  • Sigma Planning Corp's Myriad Genetics position peaked at $227K in Q1 2015.
  • 234 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2015.

Based on Sigma Planning Corp's 13F filing for Q2 2015, filed 14 Jul 2015.